Analysis of Pleiotropic Effects of Nivolumab in Patients with Relapsed Pleural Mesothelioma: A Single-Center Retrospective Study
Nivolumab demonstrated efficacy and safety in clinical practice, supporting its use in patients with good PS, even in later lines.
Authors
- Tomoki Higashiyama
- Toshiyuki Minami (ORCID: https://orcid.org/0000-0001-7421-8457)
- Takashi Kijima (ORCID: https://orcid.org/0000-0003-4249-4021)
- Kozo Kuribayashi (ORCID: https://orcid.org/0000-0002-8007-1516)
- Aki Kubota
- Akifumi Nakamura (ORCID: https://orcid.org/0000-0001-5742-9527)
- Taiichiro Otsuki (ORCID: https://orcid.org/0009-0004-1473-6892)
- Kazuhiro Kitajima (ORCID: https://orcid.org/0000-0002-9553-996X)
- Hiroshi Doi (ORCID: https://orcid.org/0000-0003-3237-2119)
- Ryo Takahashi (ORCID: https://orcid.org/0000-0002-5360-4313)
- Koji Mikami (ORCID: https://orcid.org/0000-0003-3811-0072)
- Y. Nakajima (ORCID: https://orcid.org/0000-0002-2744-5216)
- Daichi Fujimoto
Institutions
- Hyogo University (JP)
- Kindai University (JP)
Publication Details
- Journal
- Oncology
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1159/000543414
- Citations
- 1
- Primary Topic
- Occupational and environmental lung diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.52